Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

Paris, FR
Size (employees)
106,859 (est)
Sanofi was founded in 2004 and is headquartered in Paris, FR
Report incorrect company information

Key People/Management at Sanofi

Olivier Brandicourt

Olivier Brandicourt

Olivier Charmeil

Olivier Charmeil

Executive Vice President and General Manager
Jerome Contamine

Jerome Contamine

Executive Vice President & Chief Financial Officer
Karen Linehan

Karen Linehan

Executive Vice President, Legal Affairs and General Counsel
David Loew

David Loew

Executive Vice President and General Manager of Sanofi Pasteur
Philippe Luscan

Philippe Luscan

Executive Vice President, Global Industrial Affairs
Show more

Sanofi Office Locations

Sanofi has offices in Singapore, Paris, Bridgewater, Macquarie Park and in 9 other locations
Paris, FR (HQ)
54, rue La Boétie
Macquarie Park, AU
Building D, 12-24 Talavera Road
Ontario, CA
1755 Steeles avenue West
Beijing, CN
7th floor, n°112, Jian Guo Lu, Chaoyang District
Hong Kong, HK
Room 2504-2511, Windsor House, 311, Gloucester Road, Causeway Bay
New Delhi, IN
D-2, Fourth Floor, Southern Park, DDA Commercial Centre, Saket
Show all (13)
Report incorrect company information

Sanofi Financials and Metrics

Sanofi Revenue

Embed Graph
Sanofi's revenue was reported to be €37.06 b in FY, 2015 which is a 9.7% increase from the previous period.

Revenue (FY, 2015)

37.1 b

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

26.1 b

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

4.4 b
EURFY, 2013FY, 2014FY, 2015


33 b33.8 b37.1 b

Revenue growth, %


Cost of goods sold

10.3 b10.2 b10.9 b

Gross profit

22.6 b23.5 b26.1 b
EURFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

6.4 b6.3 b7.2 b
EURY, 2015


365.4 k
Show all financial metrics

Sanofi Operating Metrics

Y, 2013Y, 2014Y, 2015Y, 2016

Drugs Approved by FDA


Phase III Trials Products

11 9 8 7

Projects in R&D Pipeline

36 32 34 43
Show all operating metrics

Sanofi Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Ablynx January 29, 2018$4.80 b
Bioverativ January 22, 2018$11.60 b

Sanofi Revenue Breakdown

Embed Graph

Sanofi revenue breakdown by business segment: 80.4% from Pharmaceuticals, 12.8% from Vaccines and 6.8% from Animal Health

Report incorrect company information

Sanofi Online and Social Media Presence

Embed Graph
Report incorrect company information

Sanofi Company Life and Culture

Report incorrect company information